Gemcitabine plus epirubicin plus taxol (GET) in advanced breast cancer: A phase II study

P. F. Conte, A. Gennari, S. Donati, B. Salvadori, E. Baldini, C. Bengala, I. Pazzagli, C. Orlandini, R. Danesi, S. Fogli, M. Del Tacca

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Gemcitabine plus epirubicin plus taxol (GET) in advanced breast cancer: A phase II study'. Together they form a unique fingerprint.

Medicine & Life Sciences